Related Experiment Video
Updated: May 23, 2026

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy
Published on: March 29, 2024
Disseminated candidiasis developing during prophylaxis with fluconazole in a small-intestine transplant recipient
Sükran Köse1, Melda Türken, Gülgün Akkoçlu
1Izmir Tepecik Education and Research Hospital, Izmir, Turkey.
Abstract:
A 31-year-old man underwent immunosuppressive treatment and was treated with 150 mg per day of prophylactic oral fluconazole after receiving a small-intestine transplant. The patient had acute rejection by the end of the first week after the transplant. Endoscopic examination showed white plaques. In blood and urine cultures, growth of Candida albicans was detected. Biopsy specimens showed high levels of conidia and hyphae in all regions. Intravenous treatment with caspofungin was started for the patient. Candidal findings had regressed on follow-up endoscopy. However, the patient died 3 months after transplant because of the effects of immunosuppression on his bone marrow and the development of disseminated intravascular coagulation. Candida species are the most common cause of invasive fungal infections that develop after solid-organ transplant. Following transplant, candidemia may develop during systemic antifungal treatment with a high level of mortality.
Insights
A small-intestine transplant patient on antifungal prophylaxis developed invasive candidiasis. Despite treatment, the patient died from complications related to immunosuppression and disseminated intravascular coagulation.
Area of Science:
- Medicine
- Transplant Surgery
- Mycology
Background:
- Solid-organ transplant recipients often require immunosuppressive therapy, increasing susceptibility to opportunistic infections.
- Prophylactic antifungal medication is common in transplant patients to prevent fungal infections.
Observation:
- A 31-year-old male received a small-intestine transplant and prophylactic oral fluconazole.
- The patient experienced acute rejection and presented with white plaques on endoscopy.
- Blood and urine cultures revealed Candida albicans, with biopsy confirming fungal elements.
Findings:
- Invasive candidiasis developed despite prophylactic fluconazole.
- Intravenous caspofungin treatment led to regression of candidal findings on endoscopy.
- The patient ultimately died three months post-transplant due to bone marrow suppression and disseminated intravascular coagulation.
Implications:
- Candida species are a significant cause of invasive fungal infections in transplant recipients.
- Candidemia can occur even with systemic antifungal treatment, carrying a high mortality risk.
- Close monitoring for invasive fungal infections is crucial in immunocompromised transplant patients.
Related Concept Videos
Fungal Phylum Microsporidia
Antifungal Agents
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

